LI ZHILIN (CEO and interim CFO) received a stock award from CHINA PHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/13/2021ACC: 0001213900-21-047830
DirectorOfficer10% Owner· CEO and interim CFO
Since Dec 2020
+1.76M
Net shares
Net buyer
$1.18M
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.76M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.76M
Price / share
$0.67
Trade value
$1.18M
% of position
14.6%
9/9/2021
12.05M→13.81M
Total
Net shares
+1.76M
Net value
$1.18M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2021 | A · Award | +1.76M | $0.67 | $1.18M | 14.6% | 12.05M | 13.81M |
| Total | +1.76M | $1.18M | ||||||
Derivative Transactions0
No derivative transactions reported